DD
44
2
EQR
33
6
GME
61
2
FSLR
50
6
PRU
39
3
MDT
59
4
ADT
12
2
RL
73
5
NWL
48
4
VRSK
54
2
FOX
71
3
AXP
63
3
ADBE
50
3
CTAS
36
8
NI
63
5
PSA
43
6
NKE
36
2
DNB
72
4
JCI
44
7
VMC
41
2
DD
44
2
EQR
33
6
GME
61
2
FSLR
50
6
PRU
39
3
MDT
59
4
ADT
12
2
RL
73
5
NWL
48
4
VRSK
54
2
FOX
71
3
AXP
63
3
ADBE
50
3
CTAS
36
8
NI
63
5
PSA
43
6
NKE
36
2
DNB
72
4
JCI
44
7
VMC
41
2
Financhill
Back

Genmab AS Vs. Ascendis Pharma AS Industry Stock Comparison

Sell
19

GMAB
Genmab AS

Last Price:
$20.31
Seasonality Move:
3.07%
Sell
43

ASND
Ascendis Pharma AS

Last Price:
$136.20
Seasonality Move:
19.34%
Sell
19
Genmab AS (GMAB) is a Sell

Is Genmab AS a Buy, Sell or Hold?

  • The current Genmab AS [GMAB] share price is $20.31. The Score for GMAB is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • GMAB is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
43
Ascendis Pharma AS (ASND) is a Sell

Is Ascendis Pharma AS a Buy, Sell or Hold?

  • The current Ascendis Pharma AS [ASND] share price is $136.24. The Score for ASND is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • ASND is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GMAB Stock Price Chart

What is Genmab AS's stock price today?

  • The Genmab AS share price today is $20.31
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GMAB is experiencing slight buying pressure.

ASND Stock Price Chart

What is Ascendis Pharma AS's stock price today?

  • The Ascendis Pharma AS share price today is $136.24
    The current trend is moderately bullish and ASND is experiencing selling pressure, which indicates risk of future bearish movement.

GMAB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.49 Sell
Relative Strength Index (14 RSI): 36.61 Sell
Chaikin Money Flow: 304947 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (20.25 - 21.61) Sell
Bollinger Bands (100): (21.47 - 26.57) Sell

ASND Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.94 Buy
Relative Strength Index (14 RSI): 55.46 Buy
Chaikin Money Flow: -494298 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (126.97 - 136.41) Buy
Bollinger Bands (100): (123.93 - 140.99) Buy

GMAB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 20.37 Sell
20-day SMA: 21.02 Sell
50-day SMA: 21.85 Sell
200-day SMA: 26.17 Sell
8-day EMA: 20.44 Sell
20-day EMA: 20.92 Sell
50-day EMA: 21.95 Sell
200-day EMA: 25.7 Sell

ASND Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 135.21 Buy
20-day SMA: 133.62 Buy
50-day SMA: 129.61 Buy
200-day SMA: 135.21 Buy
8-day EMA: 135.55 Buy
20-day EMA: 133.34 Buy
50-day EMA: 131.96 Buy
200-day EMA: 130.87 Buy

Genmab AS Earnings Growth & GMAB Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.15 per share, and an increase next year of $0.28 per share.

Ascendis Pharma AS Earnings Growth & ASND Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.48 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.98 per share, and an increase next year of $3.81 per share.

Genmab AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ascendis Pharma AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):